Giovanni Rubegni,Paolo Ferri,Emanuele Mocciardini,Luca Mapelli,Gaetano Savaresi,Rebecca Prandini,Leonardo Colombo,Alessandra Cartocci,Gian Marco Tosi,Luca Rossetti
{"title":"Smartphone-Driven Augmented Reality Headset for Low-Light Mobility Assistance in Retinitis Pigmentosa.","authors":"Giovanni Rubegni,Paolo Ferri,Emanuele Mocciardini,Luca Mapelli,Gaetano Savaresi,Rebecca Prandini,Leonardo Colombo,Alessandra Cartocci,Gian Marco Tosi,Luca Rossetti","doi":"10.1016/j.ajo.2025.09.048","DOIUrl":null,"url":null,"abstract":"PURPOSE\r\nTo evaluate the effectiveness of a smartphone-driven augmented reality (AR) headset in expanding the functional visual field and improving mobility performance under low-light conditions in patients with retinitis pigmentosa (RP).\r\n\r\nDESIGN\r\nProspective, single-center before-and after study.\r\n\r\nSUBJECTS\r\nThirty-two patients (18 females, 14 males; median age: 55.5 years) with genetically confirmed typical RP, a binocular uncorrected distance visual acuity (BUVA) of ≥20/200, and VF restricted to <10° in both eyes.\r\n\r\nMETHODS\r\nParticipants were assessed at baseline and under AR-assisted conditions. The AR system consisted of XREAL One glasses paired with an iPhone 15. Visual function was evaluated through ETDRS visual acuity, Pelli-Robson contrast sensitivity, and tangent screen perimetry. Functional mobility was assessed using the Multi-Luminance Mobility Test (MLMT). Data were analyzed using paired t-tests and Wilcoxon signed-rank tests.\r\n\r\nMAIN OUTCOME MEASURES\r\nThe primary outcome was the change in MLMT score, secondary outcomes included changes in binocular visual field area, contrast sensitivity, and uncorrected binocular visual acuity (BUVA) with and without the AR device.\r\n\r\nRESULTS\r\nUse of the AR headset resulted in a ∼3.4-fold enlargement in binocular VF (p < 0.001) and a median improvement of 3 points in MLMT score (from median 3 to 6; p < 0.001). The proportion of patients able to complete the MLMT at 1 lux increased from 0% to 88%. While standard minification mode reduced BUVA by 0.58 logMAR (p < 0.001), the 4× mode maintained baseline acuity (p = 0.166) and improved contrast sensitivity (p < 0.001).\r\n\r\nCONCLUSIONS\r\nThis study demonstrates that a consumer-grade AR headset combined with a smartphone can deliver substantial improvements in low-light mobility and visual field function for RP patients, offering a scalable and affordable alternative to conventional low-vision aids. These findings highlight the potential of leveraging consumer technologies for accessible, patient-centered visual rehabilitation.","PeriodicalId":7568,"journal":{"name":"American Journal of Ophthalmology","volume":"108 1","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajo.2025.09.048","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
PURPOSE
To evaluate the effectiveness of a smartphone-driven augmented reality (AR) headset in expanding the functional visual field and improving mobility performance under low-light conditions in patients with retinitis pigmentosa (RP).
DESIGN
Prospective, single-center before-and after study.
SUBJECTS
Thirty-two patients (18 females, 14 males; median age: 55.5 years) with genetically confirmed typical RP, a binocular uncorrected distance visual acuity (BUVA) of ≥20/200, and VF restricted to <10° in both eyes.
METHODS
Participants were assessed at baseline and under AR-assisted conditions. The AR system consisted of XREAL One glasses paired with an iPhone 15. Visual function was evaluated through ETDRS visual acuity, Pelli-Robson contrast sensitivity, and tangent screen perimetry. Functional mobility was assessed using the Multi-Luminance Mobility Test (MLMT). Data were analyzed using paired t-tests and Wilcoxon signed-rank tests.
MAIN OUTCOME MEASURES
The primary outcome was the change in MLMT score, secondary outcomes included changes in binocular visual field area, contrast sensitivity, and uncorrected binocular visual acuity (BUVA) with and without the AR device.
RESULTS
Use of the AR headset resulted in a ∼3.4-fold enlargement in binocular VF (p < 0.001) and a median improvement of 3 points in MLMT score (from median 3 to 6; p < 0.001). The proportion of patients able to complete the MLMT at 1 lux increased from 0% to 88%. While standard minification mode reduced BUVA by 0.58 logMAR (p < 0.001), the 4× mode maintained baseline acuity (p = 0.166) and improved contrast sensitivity (p < 0.001).
CONCLUSIONS
This study demonstrates that a consumer-grade AR headset combined with a smartphone can deliver substantial improvements in low-light mobility and visual field function for RP patients, offering a scalable and affordable alternative to conventional low-vision aids. These findings highlight the potential of leveraging consumer technologies for accessible, patient-centered visual rehabilitation.
期刊介绍:
The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect.
The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports.
Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.